Avoro Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $97.2M | Buy |
|
|||||
|
2024
Q1 | $44.8M | Sell |
|
|||||
|
2023
Q4 | $213M | Buy |
|
|||||
|
2023
Q3 | $179M | Sell |
|
|||||
|
2023
Q2 | $210M | Hold |
|
|||||
|
2023
Q1 | $221M | Hold |
|
|||||
|
2022
Q4 | $263M | Hold |
|
|||||
|
2022
Q3 | $221M | Sell |
|
|||||
|
2022
Q2 | $198M | Buy |
|
|||||
|
2022
Q1 | $212M | Buy |
|
|||||
|
2021
Q4 | $182M | Buy |
|
|||||
|
2021
Q3 | $160M | Sell |
|
|||||
|
2021
Q2 | $170M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $69M | Buy |
|